Evidence map›Paper›PMID 25364083›Full record

ArticleSurface science reports2014

Synthesis and surface functionalization of silica nanoparticles for nanomedicine.

Alexander Liberman, Natalie Mendez, William C Trogler, Andrew C Kummel

Open access · greenAbstract read
In one paragraph

Article in Surface science reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 485 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. New binary and ternary SiOScientific reports · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. [Molecules (Basel, Switzerland) · 2024
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alexander LibermanMaterials Science and Engineering Program, University of California San Diego, 9500 Oilman Drive, La Jolla, CA 92093-0358, USA.
Natalie MendezMaterials Science and Engineering Program, University of California San Diego, 9500 Oilman Drive, La Jolla, CA 92093-0358, USA.
William C TroglerDepartment of Chemistry and Biochemistry, University of California San Diego, 9500 Oilman Drive, La Jolla, CA 92093-0358, USA.
Andrew C KummelDepartment of Chemistry and Biochemistry, University of California San Diego, 9500 Oilman Drive, La Jolla, CA 92093-0358, USA.
University of California San Diego · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Yeast Genetics and Stress Response Genes-BiomedicalP42ES010337 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TUKEY, ROBERT H · 2000 to 2022
$69.8M
UCSD Cancer Nanotechnology Training CenterR25CA153915 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KUMMEL, ANDREW CLYDE, MATTREY, ROBERT F · 2010 to 2014
$1.8M
Non-circulating microparticles for improved localization and resection cancerR21CA151140 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BLAIR, SARAH L · 2011 to 2012
$274k
In Vivo Analysis of Stationary Gas Filled Hollow Iron Doped Silica NanoshellsF31CA174276 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LIBERMAN, ALEXANDER · 2013 to 2014
$73k
NCI NIH HHS F31 CA174276NCI NIH HHS P30 CA023100NCI NIH HHS R21 CA151140NCI NIH HHS R25 CA153915NIEHS NIH HHS P42 ES010337
6 · The paper itself

Abstract

There are a wide variety of silica nanoformulations being investigated for biomedical applications. Silica nanoparticles can be produced using a wide variety of synthetic techniques with precise control over their physical and chemical characteristics. Inorganic nanoformulations are often criticized or neglected for their poor tolerance; however, extensive studies into silica nanoparticle biodistributions and toxicology have shown that silica nanoparticles may be well tolerated, and in some case are excreted or are biodegradable. Robust synthetic techniques have allowed silica nanoparticles to be developed for applications such as biomedical imaging contrast agents, ablative therapy sensitizers, and drug delivery vehicles. This review explores the synthetic techniques used to create and modify an assortment of silica nanoformulations, as well as several of the diagnostic and therapeutic applications.

Indexed as

Ablative technologyBiodistributionBiomedical imagingNanoparticlesSilicaToxicology

Identifiers

PMID25364083
PMCPMC4212223
OpenAlexW2001561235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.